SpringWorks Therapeutics gets grant for treatment of desmoid tumor with nirogacestat in specific dosages

2d ago, source: Pharmaceutical Technology

Discover the groundbreaking patent by SpringWorks Therapeutics for treating desmoid tumors with nirogacestat. Learn about the specific dosages and monitoring methods for optimal patient care.

SpringWorks Therapeutics Inc Ordinary Shares

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SpringWorks Therapeutics: Q4 Earnings Snapshot

1mon ago, source: SFGate

STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Tuesday reported a loss of $94.3 million in its fourth quarter. The Stamford, Connecticut-based company ...

RLAY Relay Therapeutics, Inc.

7d ago, source: Seeking Alpha

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule ...

SpringWorks Therapeutics Inc (SWTX)

1mon ago, source: Investing

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company has ...

SpringWorks Therapeutics Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...